AIG
VOR icon

American International Group’s Vor Biopharma VOR Stock Holding History

American International Group’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-940
Closed -$44.6K – 2651
2024
Q1 		$44.6K Buy
940
+4
+0.4% +$176 ﹤0.01% 2810
2023
Q4 		$42.1K Sell
936
-4
-0.4% -$165 ﹤0.01% 2851
2023
Q3 		$39.9K Buy
940
+33
+4% +$1.79K ﹤0.01% 2875
2023
Q2 		$56K Buy
+907
New +$82.8K ﹤0.01% 2850
2022
Q2 		– Sell
-471
Closed -$57K – 3275
2022
Q1 		$57K Sell
471
-33
-7% -$5.62K ﹤0.01% 2805
2021
Q4 		$117K Sell
504
-15
-3% -$4.32K ﹤0.01% 2651
2021
Q3 		$163K Buy
519
+199
+62% +$59.2K ﹤0.01% 2552
2021
Q2 		$119 Sell
320
-13
-4% -$6.41K ﹤0.01% 2812
2021
Q1 		$287 Buy
+333
New +$282K ﹤0.01% 2162

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American International Group's VOR Position: Q2 2024 in Review

American International Group sold out of Vor Biopharma (VOR) in Q2 2024, closing a stake of 940 shares — an estimated $44.6K sold.

American International Group first reported a position in VOR in Q1 2021 and held it in 9 quarters. The position peaked at $163K in Q3 2021. 71 funds tracked by Wall St. Rank hold VOR as of Q2 2024.

  • American International Group reported no remaining Vor Biopharma position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 940 Vor Biopharma shares in Q2 2024, an estimated $44.6K.
  • American International Group first reported a position in Vor Biopharma in Q1 2021 and held it in 9 quarters.
  • American International Group's Vor Biopharma position peaked at $163K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.